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Abstract
The aim of this study was to investigate the correlation between stone composition and sin-
gle-energy noncontrast computed tomography (NCCT) parameters, including stone hetero-
geneity index (SHI) and mean stone density (MSD), in patients with urinary calculi. We
retrospectively reviewed medical records of 255 patients who underwent operations or pro-
cedures for urinary stones or had spontaneous stone passage between December 2014
and October 2015. Among these, 214 patients with urinary calculi who underwent NCCT
and stone composition analyses were included in the study. Maximal stone length (MSL),
mean stone density (MSD), and stone heterogeneity index (SHI) were determined on pre-
treatment NCCT. The mean MSD (454.68±177.80 HU) and SHI (115.82±96.31 HU) of uric
acid stones were lower than those of all other types. Based on post hoc tests, MSD was
lower for uric acid stones than for the other types (vs. CaOx: P<0.001; vs. infection stones:
P<0.001). SHI was lower for uric acid stones than for the other types (vs. CaOx: P<0.001;
vs. infection stones: P<0.001) Receiver operating characteristic curves of uric acid stones
for MSD and SHI demonstrated that SHI (cut-off value: 140.4 HU) was superior to MSD
(cut-off value: 572.3 HU) in predicting uric acid stones (P<0.001).
Introduction
Pretreatment determination of urinary stone composition can be essential for optimal stone
management [1]. It is important for three reasons. Firstly, the composition is related to hard-
ness, which in turn affects the outcomes of extracorporeal shockwave lithotripsy (ESWL), ure-
teroscopic lithotripsy (URSL), and retrograde intra-renal surgery (RIRS) [2]; hard stones may
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be resistant to shock-wave and Holmium:YAG laser [3]. Mean stone density (MSD), as repre-
sented by the mean Hounsfield unit (HU) value measured during non-contrast computed
tomography (NCCT), can be related to stone hardness [4]. Secondly, stones occurring with
various metabolic syndromes, such as cysteine stones or uric acid stones, may require systemic
medical treatment for chemolitholysis [5]. Finally, knowing a stone’s composition is useful for
preventive efforts, and it can be a condition for chemoprevention and regulating life-style
modification. [6].
Although stone composition is important for treatment decisions, it is often difficult to be
certain of the composition. NCCT has become the gold standard for diagnosis of urolithiasis
nowadays, as it provides information regarding stone size and location [7]. Furthermore, sev-
eral studies have reported being able to predict stone characteristics with HUs, including sev-
eral HU-related parameters [8].
Recently, the newly reported stone heterogeneity index (SHI), which is a proxy of stone var-
iation, was defined as the standard deviation of the mean HU in a region of interest on NCCT;
it was proposed as a novel predictor for ESWL outcomes in patients with ureteral stones [9].
Lee et al. reported that SHI could be a useful clinical parameter for stone fragility and hardness
(which can affect the outcomes of ESWL) and an independent predictor of ESWL success rate.
However, stone composition could not be analyzed in that study because of the effects of
ESWL; this was a major limitation of their study. Thus, in the current study we investigated
the correlation between pretreatment NCCT parameters, such as SHI and MSD, and stone
composition.
Materials and methods
Patient cohort
Medical records were obtained from our hospital database for 255 patients who underwent
surgical operations or procedures or had spontaneous urinary stone passage between Decem-
ber 2014 and October 2015 at Severance Hospital, Seoul, Korea. Inclusion criteria were as fol-
lows: (1) NCCT performed before treatment or spontaneous stone passage; and (2) the target
stone measured by NCCT was retrieved and its stone composition was analyzed. Patients with
urinary tract congenital anomalies, single kidney, or preoperative receipt of stone-dissolving
medication (including potassium citrate, tiopronin, and antibiotics) were excluded from the
study. Surgical operations or procedures included URSL, ESWL, percutaneous nephrolithot-
omy (PCNL), RIRS, vesicolitholapaxy (VESL), laparoscopic ureterolithotomy (LAPU), and
laparoscopic pyelolithotomy (LAPP). A total of 214 patients were included in the study.
Good clinical practice protocols
The study was performed in accordance with all applicable laws and regulations, good clinical
practices, and ethical principles described in the Declaration of Helsinki. The Institutional
Review Board of the Severance Hospital approved the study protocol (Approval No. 4-2015-
0947). The study was exempted from requiring written informed consent from the participants
because of its retrospective design and because the patients’ records and information were
anonymized and de-identified prior to analysis.
Stone characteristics on non-contrast computed tomography
Stone characteristics included the location, size, MSD, and SHI. We used the GE Centricity
system (GE Healthcare Bio-Sciences Corp., Piscataway, NJ, USA) to obtain measurements.
The stone size was determined from the largest stone diameter on the axial or coronal plane of
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NCCT. HU was measured on the magnified, axial NCCT image from the point of the largest
stone diameter, where the elliptical region of interest incorporated the largest cross-sectional
area of the stone without including the adjacent soft tissue. MSD was defined as the mean
value of HU in the region of interest, and SHI was defined as the standard deviation of HU in
the same region of interest. In this study, HU was measured by two researchers (H.D.J and J.S.
L), and if there were any significant differences, the third researcher (J.Y.L) performed mea-
surement again and corrected it. We measured target stones in both pre-treatment NCCT and
post-treatment NCCT. In bilateral cases, we obtain two stone composition results; in this case,
we divided two samples in dataset.
Stone composition analysis
Stone composition quantitative analysis was performed using Fourier-Transform Infrared
Spectrometry (FT-IRS). The FT-IRS was carried out in Green Cross Laboratories, Yongin,
Korea.
Statistical analysis
Data are presented as mean±standard deviation, except where otherwise indicated. Statistical
comparisons of continuous variables from patient demographic information were performed
using either Student’s or Welch’s two-sample t-tests or Wilcoxon rank-sum test. In the sub-
group analyses, one-way analysis of variance (ANOVA) was used. After ANOVA, Tukey–Kra-
mer’s post hoc tests were used for comparisons between groups. Categorical variables were
compared using Pearson’s chi-squared test. Optimal cut-off values for significant values were
identified from receiver operating characteristic (ROC) curves using Youden methodology.
Statistical analyses were performed using R software (version 3.3.2, R Foundation for Statistical
Computing, Vienna, Austria; http://www.r-project.org) and its OptimalCutpoints package for
determining the optimal cut-off values.
Results
Demographic and stone characteristics of all patients
The mean age of total patients was 54.86±15.59 years. The distribution of operations and proce-
dures included 9 cases of ESWL, 2 cases of LAPP, 14 cases of LAPU, 36 cases of PCNL, 19 cases
of RIRS, 114 cases of URSL, and 12 cases of VESL. There were 8 cases of spontaneous stone pas-
sage. Sixty cases were renal stones. Ureter stones included 69 cases of upper ureter stones, 12
cases of midureter stones, and 62 cases of lower ureter stones. Eleven cases were bladder stones.
The mean MSL was 12.77±9.07 mm, the MSD was 670.06±304.00 HU, and the SHI was 241.61
±126.61 HU (Table 1). Stone composition analyses revealed 140 calcium oxalate (CaOx) stones,
which included 51 monohydrate stones, 59 mixed stones with 80% CaOx monohydrate
(MH), 10 mixed stones with< 80% CaOxMH, and 20 mixed CaOxMH and dehydrate (DH)
stones. Infection stones included 23 carbonate apatite stones and 10 struvite stones. There were
41 cases of uric acid stones. Table 2 demonstrates the patient and stone characteristics according
to stone composition. As shown in Figs 1 and 2, MSD (454.68±177.80 HU) and SHI (115.82
±96.31) of uric acid stones were lower than for the other types of stones.
Analyses of three stone groups: Calcium oxalate, infection, and uric acid
stones
As shown in Table 1, there were statistically significant differences for mean age, MSL, MSD,
and SHI among the three groups of stones (CaOx compounds inclung MH and DH, infection
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stones, and uric acid stones). Based on post hoc tests, patients with CaOx were younger than
those with uric acid stones (P = 0.005). The MSL was greater for uric acid stones than for the
other types of stones (vs. CaOx: P<0.001; vs. infection stones: P<0.001); however, there were
no differences in MSL between CaOx and infection stones (P = 0.679). The MSD was lower for
uric acid stones than for the other types of stones (vs. CaOx: P<0.001; vs. infection stones:
P<0.001). The SHI was lower for uric acid stones than for the other types (vs. CaOx: P<0.001;
vs. infection stones: P<0.001); however, there were no significant differences in MSD
(P = 0.139) and SHI (P = 0.175) between CaOx and infection stones.
ROC curves and cut-off values of MSD and SHI for predicting uric acid
stones
For MSD, the area under the ROC curve (AUC) was 0.766 (95% confidence interval [CI],
0.696–0.836), and the cut-off value was 572.3 HU. For SHI, the AUC was 0.885 (95% CI,
0.824–0.945), and the cut-off value was 140.4 HU (Fig 3). Comparing MSD to SHI in their abil-
ity to predict uric acid stones, SHI was superior to MSD based on DeLong’s test for two corre-
lated ROC curves (P<0.001). Sensitivity and specificity of MSD for uric acid stones were 0.624
Table 1. Patient and stone data for the total cohort and three groups including calcium oxalate, infection, and uric acid stones.
Total cohort CaOx compound Infection Uric acid P-value
No. of patients 214 140 33 41
Age 54.86±15.59 52.56±16.19 55.67±13.81 62.05±12.61 0.002a
Sex 0.374b
Male 85 20 30
Female 55 13 11
Procedures
ESWL 9 7 1 1
LAPP 2 1 0 1
LAPU 14 10 3 1
PCNL 36 11 11 14
RIRS 19 14 3 2
URSL 114 90 10 14
VESL 12 1 5 6
Spontaneous passage 8 6 0 2
Location
Kidney 60 27 17 16
Upper ureter 69 51 8 10
Midureter 12 11 0 1
Lower ureter 62 50 4 8
Bladder 11 1 4 6
MSL 12.77±9.07 9.61±5.05 19.61±12.49 18.05±11.08 <0.001a
MSD 670.06±304.00 701.09±297.37 806.01±329.87 454.68±177.80 <0.001a
SHI 241.61±126.61 278.73±112.10 240.43±119.28 115.82±96.31 <0.001a
Data are mean±standard deviation or number.
CaOx: calcium oxalate; ESWL: extracorporeal shock wave lithotripsy; LAPP: laparoscopic pyelolithotomy; LAPU: laparoscopic ureterolithotomy; PCNL: percutaneous
nephrolithotripsy; RIRS: retrograde intra-renal surgery; URSL: ureteroscopic lithotripsy; VESL: vesicolitholapaxy; MSL: maximal stone length; MSD: mean stone
density; SHI: stone heterogeneity index
a. Based on one-way ANOVA
b. Based on Pearson’s chi-squared tests with Yates’ continuity correction
https://doi.org/10.1371/journal.pone.0193945.t001
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(95% CI 0.548–0.697) and 0.902 (95% CI 0.769–0.973), respectively. SHI demonstrated that
sensitivity and specificity were 0.855 (95% CI 0.794–0.904) and 0.829 (95% CI 0.679–0.928) for
uric acid stones. Positive predictive value was 0.964 (95% CI 0.907–0.974) and negative predic-
tive value was 0.362 (95% CI 0.293–0.687) in uric acid stone using MSD. In SHI, positive and
negative predictive values for uric acid stone were 0.955 (95% CI 0.902–0.971) and 0.576 (95%
CI 0.470–0.784), respectively.
Discussion
In the first study to examine the relationship between stone composition and NCCT parame-
ters, Spettel et al. reported that uric acid stones exhibited significantly different MSD (as deter-
mined by the average HU on NCCT) compared with other stones [10]. They suggested that an
MSD 500 and a pH 5.5 had a positive predictive value of 90% for uric acid composition in
stones> 4 mm. Urine pH, the presence of crystals, urease-positive bacteria in the urine, plain
Table 2. Patient and stone characteristics according to stone composition.
n Male:Female Age
(year)
Stone length (mm) NCCT values (HU)
Min Max MSD SHI
CaOx
MH 100% 51 34:17 57.06±13.99 8.82±3.76 151.25±113.36 1187.90±379.33 716.06±297.52 295.27±107.86
MH80% 59 29:30 53.80±15.22 10.91±6.07 174.34±89.95 1248.81±402.86 768.47±287.83 298.14±109.92
MH<80% 10 6:4 53.10±14.42 10.04±4.44 146.70±133.89 937.80±417.17 557.91±273.49 225.91±122.36
MH+DH 20 16:4 37.15±16.98 7.58±4.00 175.05±81.46 889.55±380.79 535.72±267.20 205.69±91.36
Carbonate apatite 23 14:9 55.57±14.72 18.62±10.80 162.13±83.04 1182.78±396.46 788.90±299.48 240.42±92.05
Struvite
80% 4 1:3 53.75±7.97 18.50±19.92 193.50±123.69 1067.50±764.64 656.62±338.68 235.08±253.03
<80% 6 3:3 57.33±14.94 24.17±14.75 306.50±130.58 1342.50±602.93 971.17±425.46 244.07±123.77
Uric acid 100% 41 11:30 62.05±12.61 18.05±11.08 167.83±97.02 676.93±348.89 454.68±177.80 115.82±96.31
Data are mean±standard deviation or number.
CaOx: calcium oxalate; MH: monohydrate; DH: dehydrate; NCCT: noncontrast computed tomography; Min: minimum; Max: maximum; MSD: mean stone density;
SHI: stone heterogeneity index
https://doi.org/10.1371/journal.pone.0193945.t002
Fig 1. Mean stone density in noncontrast computed tomography values according to stone composition. CA: carbonate apatite; CaOx: calcium oxalate; MH:
monohydrate; DH: dehydrate; UA: uric acid.
https://doi.org/10.1371/journal.pone.0193945.g001
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x-ray appearance, and a history of urinary stones have long been used to predict the composi-
tion of stones [11]. However, a recent report showed no relationship between urine pH and
stone composition. In their study evaluating the relationships among body mass index (BMI),
visceral fat, urine pH, and stone composition, Kim et al. concluded that visceral fat adiposity
strongly correlated with the presence of uric acid stones and had better predictive value than
BMI or urine pH in classifying the type of stone [12]. The main reason for the lack of a
Fig 2. Stone heterogeneity index in noncontrast computed tomography values according to stone composition. CA: carbonate apatite; CaOx: calcium oxalate; MH:
monohydrate; DH: dehydrate; UA: uric acid.
https://doi.org/10.1371/journal.pone.0193945.g002
Fig 3. Receiver operating characteristic (ROC) curve of uric acid stones for mean stone density and stone heterogeneity index. (A) The area under the ROC curve
(AUC) for the mean stone density was 0.766 (95% confidence interval [CI], 0.696–0.836) and the cut-off value was 572.3 HU. (B) The AUC for the stone heterogeneity
index was 0.885 (95% CI, 0.824–0.945) and the cut-off value was 140.4 HU.
https://doi.org/10.1371/journal.pone.0193945.g003
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relationship between urine pH and stone composition may have been selection bias because of
the diurnal variation of urine pH. The relationship between stone composition and MSD has
been also determined by in vitro studies [13,14]. Classifying stones as urate, phosphate, and
oxalate stones, different HU values have been found (urate: 513±197 HU; phosphate: 1660
±292 HU; and oxalate: 1684±290 HU).
NCCT has become the gold standard for diagnosing urolithiasis [7]. NCCT can provide an
abundance of information, including the size, number, and location of stones, and the pres-
ence of hydronephrosis [15]. However, there is now an interest in determining stone composi-
tion with NCCT, as stone composition can affect clinical decision-making and the outcomes
of several therapeutic procedures. Dual-energy computed tomography (DECT) is a promising
new technology that has the potential to improve our current ability to determine stone com-
position [16]. DECT was demonstrated to be effective for predicting uric acid and CaOx com-
pound stones [17]. However, DECT has not become popular, and it has a higher risk of
radiation hazards than low-dose or ultra-low-dose NCCT. In some countries, the price of
DECT is higher than that of single-energy NCCT.
During the last decade, MSD has been a widely used NCCT parameter for characterizing
urinary stones for both research purposes and clinical practice [18]. MSD can be a factor
related to stone hardness; however, it is only an arithmetical average that cannot represent the
heterogeneity of stone composition [9]. SHI has been defined as the standard deviation of the
HU in a region of interest on NCCT [15]. The standard deviation of a random variable, statisti-
cal population, data set, or probability distribution is the square root of its variance. SHI is an
index presenting the radiological heterogeneity of a urinary stone. Thus, SHI can represent the
internal diversity of a stone, reflecting not only the heterogeneity of the stone’s composition
but also the stone’s structural and morphological heterogeneity [9]. In a previous study of SHI
by Lee et al., patients with uric acid stones may not have been included because the patients
were selected on the basis of having radio-opaque ureter stones that could be treated easily by
ESWL. By contrast, in the present study, we performed surgical intervention and extracted the
stones, regardless of their x-ray opacity. This allowed us to demonstrate in the current study
that SHI can be more powerful than MSD in predicting uric acid stones. Therefore, in uric
acids stones, SHI can have two meanings in NCCT. First, since uric acid stone has low MSD
and low SHI, SHI can serve as a predictor of uric acid stone. Another is that the formation of
CaOx compound 100% stone in the density of NCCT is not homogeneous.
The European Association of Urology guidelines recommended that stone composition
analysis be performed in all first-time stone formers [19] and conventionally, stone composi-
tion has been undoubtedly important in determining the efficacy of stone treatments, espe-
cially surgical interventions. The most significant differences have been found between
radiolucent uric acid calculi (easily fragmented with shock-wave and dusted by Holmium:
YAG laser) and relatively radiolucent cysteine calculi (often refractory to shock wave) [20].
Again, accurate prediction of the composition of urinary calculi is essential for choosing the
optimal decision for treatment.
During the last 2 decades, the relationships between HU and stone composition have been
investigated. Several studies demonstrated that stone composition could be predicted with
high accuracy with an in vitro approach using HU and MSD [21–23]. Furthermore, Williams
et al. suggested that knowing the major composition of a stone alone may not allow adequate
prediction of its fragility during lithotripsy treatment, but variations in internal stone struc-
ture, including secondary mineral composition, may be a significant cause of variability of
stone fragility [24]. Therefore, if both the internal structure and the composition of stone can
be predicted, the combination may be the most significant predictor of fragility during litho-
tripsy treatment. Furthermore, Zarse et al. suggested that it is stone morphology, rather than
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X-ray attenuation, that correlates with fragility to shock waves in this common stone type [25].
Their report was very important regarding the microstructure of urinary stones; however,
their focus was on CaOx compounds. Although not included in our study, cysteine stone has
high MSD and low SHI, which may help with the discovery of cysteine stone in advance. In
particular, if the presence of uric acid stones can be predicted, these stones can be expected to
have better success rates with surgical intervention and possibly chemolitholysis or chemopre-
vention. Therefore, it will be possible to make more precise treatment decisions. In the current
study, we have proposed a uric acid stone prediction model using MSD and SHI and reported
corresponding cut-off values. Similar to the results of previous reports, uric acid stones were
predictable when the MSD was < 572.3 HU. For SHI, our current results suggest that uric acid
stones can be predicted when the SHI is < 140.4 HU. SHI has sensitivity and specificity were
0.855 (95% CI 0.794–0.904) and 0.829 (95% CI 0.679–0.928) for uric acid stones. This can be
also confirmed by the ROC curve, and it can be confirmed that SHI is a more efficient factor
in predicting uric acid stone than MSD.
This study has some inherent limitations because of its retrospective design, which may
have introduced sampling bias. However, we were able to assemble a relatively large cohort of
patients with various types of stone composition. This was possible, in part, because of the
expanded indications for flexible ureteroscopic lithotripsy or retrograde intra-renal surgeries.
Another limitation is that the actual proportion of uric acid stones was higher than the known
incidence of approximately 10% in the general population. This may be because patients who
were transferred to our tertiary hospital were less likely to be treated successfully with ESWL
or medical expulsive therapy using tamsulosin, which may have increased the likelihood that
they had uric acid stones. However, our relatively high percentage of uric acid stones allowed
us to gain convincing evidence of the usefulness of SHI as NCCT parameters for predicting
these types of stones. Before analyzing the results of this study, we believed that MSD and SHI
did not affect our treatment choices. With our results, we have been influencing the choice of
treatment and believe it should be presented as an option for treatment in the future. Also,
additional research is needed to propose a model that predicts more accurate cut-off values
and successful outcomes. To this day, MSL has been considered as the most powerful factor
for success rate. The second powerful factor is MSD. In the same MSL and MSD stones, SHI
can influence outcome success. However, in PCNL and URSL, surgeon’s skill can be a major
factor for achieving stone-free status. Therefore, influences by these factors should be analyzed
in a large-scale study.
Conclusions
To our knowledge, this is the first study to report the relationship between stone composition
and SHI. We proposed that SHI can be a useful new parameter to provide additional informa-
tion to help discriminate stone composition. Our data indicate that SHI can predict uric acid
stones, with a cut-off value of 140.4 HU. Using SHI to predict uric acid stones will provide a
good opportunity to achieve improved success rates through surgical intervention and possibly
chemolitholysis and chemoprevention.
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